2 Houston schools receive $44.2 million research and innovation grant

The money will accelerate existing projects.

Photo by Nitat Termmee/Getty Images

The University of Houston and Baylor College of Medicine have been awarded a sizable grant to create a regional research hub.

The National Center for Advancing Translational Research awarded the $44.2 million Clinical and Translational Science Award Program grant to the two schools, which will work to create a regional hub called the Consortium for Translational and Precision Health. CTPH will “serve as a support for infrastructure, services, community engagement and workforce development to advance research and drive innovation in clinical translational science,” per a UH news release.

The hub plans to build on the existing partnership with UH and Baylor, as well as other clinical and research groups within the Texas Medical Center. CTPH aims to connect regional investigators with community healthcare organizations and government agencies that contribute to clinical research, healthcare, and policy. The new hub plans to provide funding for projects in pilot, and support ongoing research to help “accelerate the pace of research from discovery to population level impact,” according to the release. Over 60 leading medical institutions receive CTSA Program funding.

“Research is the engine empowering health care’s life-changing advancements,” UH President Renu Khator says in a news release. “This innovative hub will be a catalyst for groundbreaking discoveries and treatments that improve people’s quality of life. That’s what drives us at UH and we’re ecstatic to cofound a regional hub for change alongside Baylor.”

Leading the program will be Dr. Christopher Amos, professor and director of the Institute for Clinical and Translational Research (ICTR) at BCM; Dr. Fasiha Kanwal, professor of medicine and chief of the section of gastroenterology and hepatology at BCM; and Dr. Bettina M. Beech, clinical professor of population health and the chief population health officer at UH.

The CTPH will also work with Tilman J. Fertitta Family College of Medicine, Andy & Barbara Gessner College of Nursing, College of Pharmacy, College of Optometry, C. T. Bauer College of Business, Cullen College of Engineering, College of Natural Sciences and Mathematics, College of Education, College of Liberal Arts and Social Sciences, and the Honors College — all UH colleges.

“We are deeply committed to advancing innovation in clinical and translational science, and this award is a significant step forward in our mission to improve population health outcomes,” Beech says in a news release. “This is a testament to the unwavering dedication and collaborative spirit of everyone involved. It truly was a team effort.”

----

This article first appeared on our sister site InnovationMap.

a major award

$2.6 million grant funds UH research towards a fentanyl vaccine

Photo by Jellybee on Unsplash

UH has received a new financial gift towards the Michael C. Gibson Addiction Research Program, which is developing a fentanyl vaccine.

The estate of Dr. William A. Gibson has granted the University of Houston a $2.6 million gift to support and expand its opioid addiction research, including the development of a fentanyl vaccine that could block the drug's ability to enter the brain.

The gift builds upon a previous donation from the Gibson estate that honored the scientist’s late son Michael, who died from drug addiction in 2019. The original donation established the Michael C. Gibson Addiction Research Program in UH's department of psychology. The latest donation will establish the Michael Conner Gibson Endowed Professorship in Psychology and the Michael Conner Gibson Research Endowment in the College of Liberal Arts and Social Sciences.

“This incredibly generous gift will accelerate UH’s addiction research program and advance new approaches to treatment,” Daniel O’Connor, dean of the College of Liberal Arts and Social Sciences, said in a news release.

The Michael C. Gibson Addiction Research Program is led by UH professor of psychology Therese Kosten and Colin Haile, a founding member of the UH Drug Discovery Institute. Currently, the program produces high-profile drug research, including the fentanyl vaccine.

According to UH, the vaccine can eliminate the drug’s “high” and could have major implications for the nation’s opioid epidemic, as research reveals Opioid Use Disorder (OUD) is treatable.

The endowed professorship is combined with a one-to-one match from the Aspire Fund Challenge, a $50 million grant program established in 2019 by an anonymous donor. UH says the program has helped the university increase its number of endowed chairs and professorships, including this new position in the department of psychology.

“Our future discoveries will forever honor the memory of Michael Conner Gibson and the Gibson family,” O’Connor added in the release. “And I expect that the work supported by these endowments will eventually save many thousands of lives.”

----

This story originally was published on our sister site, InnovationMap.

research university of houston

2 Houston schools receive $44.2 million research and innovation grant

a major award

$2.6 million grant funds UH research towards a fentanyl vaccine

Family-friendly Houston restaurant picks Missouri City for 6th location

$150 million, 12,500-seat entertainment venue coming to Houston in 2027

Eagerly-anticipated Houston barbecue joint hosts weekend preview pop-ups